January 08, 2025 04:59 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad
US drug agency says COVID-19 vaccine may be authorized before end of phase 3 trials

US drug agency says COVID-19 vaccine may be authorized before end of phase 3 trials

Aug 31, 2020, at 03:09 am

Washington/Sputnik: The US Food and Drug Administration (FDA) is ready to authorize a vaccine against COVID-19 before the end of phase three clinical trials if such a move proves to bring more benefits than risks, Stephen Hahn, the head of the FDA, told the Financial Times (FT) in an interview, which was published on Sunday.

Glenmark to conduct clinical trials in India for potential COVID-19 drug

Glenmark to conduct clinical trials in India for potential COVID-19 drug

Apr 30, 2020, at 04:58 pm

New Delhi/IBNS: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, on Thursday announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in India to conduct clinical trials on Favipiravir Antiviral tablets on COVID-19 patients.